mohd izzuan GSK ( NYSE: GSK ) shares fell in the morning hours in London after the British drugmaker reported ~ a 2% YoY decline in its Q3 2024 revenue, driven by ~ an 18% YoY drop in its vaccine sales, one of.
mohd izzuan GSK ( NYSE: GSK ) shares fell in the morning hours in London after the British drugmaker reported ~ a 2% YoY decline in its Q3 2024 revenue, driven by ~ an 18% YoY drop in its vaccine sales, one of.